| 41 |
Could you possibly forward me the 'East Sussex Primary Care Guidelines for Diabetes' which are referred to in the LES documents?
Also, could you possibly forward the 'Insulin initiation flowchart' referred to within the insulin initiation LES please? I could not find this in the previous attachments and this is a very useful summary of the process.
|
12/05/2009
|
|
08/06/2009
|
|
42
|
Please provide details of the cost-per-patient for the GP-led health centre/s in your PCT*
*Please note: Provided that the tendering process for each contract has been completed, we do not believe this information can be withheld on the grounds of commercial confidentiality, as contracts are NHS funded with public money. This should therefore permit the information to be released into the public domain
|
12/05/2009
|
|
05/06/2009
|
|
43
|
Has your provider arm achieved arms length operation? If No when will this occur? Has your provider arm achieved Direct provider Organisation (DPO/APO) status? If not are you on target to achieve this in October 2009? Have you made a decision on the future of your provider arm, for example: Community Foundation Trust, Social Enterprise or Integrated Care Trust? If you have made this decision are you taking part in any of the Department of Health Pilot schemes? The Address and Telephone Number for Provider Services if different from the PCT?
|
15/05/2009
|
|
04/06/2009
|
|
44
|
Please can I have the contact name and email address for the following: Chief Executive, Director of Finance, Director of Commissioning, PEC Chair.
|
19/05/2009
|
|
03/06/2009
|
|
48
|
Please could you send me a list of the School Nurse offices for your Primary Care Trust.
|
20/05/2009
|
|
02/06/2009
|
|
49
|
Please could you provide a full list of all expenses claims made by the chief executive of your trust within the past four years, including details of what was claimed for and the monetary amount.
|
21/05/2009
|
|
03/06/2009
|
|
50
|
How many Osteopaths are currently contracted as service providers or listed as Willing Providers in your PCT? Does your PCT commissioning policy allow GPs to refer Patients for osteopathic treatment, and in what circumstances is this recommended? How many patients were referred to osteopaths for treatment in years 2007/08 and 2008/09?
|
11/05/2009
|
|
02/06/2009
|
|
59
|
I would like to request:
Whether the Trust has commissioned any scheme to reduce prescribing of antibiotics by GPs in 2009/10;
If so, can I request details of the scheme put in place and any financial incentives or rewards offered as part of the scheme;
Was a similar scheme in place in 2008/9.
|
22/05/2009
|
|
09/06/2009
|
|
60
|
Within East Sussex Downs & Weald PCT and considering General Dental Service contracts awarded to General Dental Practitioners for the financial year 2009/2010:
1. Have the values of Units of Dental Activity (UDAs) been harmonised across the PCT, and if so, at what value?
2. Does the PCT have a policy of harmonising, or reducing the spread of UDA values in the future?
3. How many General Dental Practitioners have not been offered a restricted (children/exempt only) contract in 2009/2010, having held a restricted contract in 2008/2009?
4. How many General Dental Practitioners have carried forward UDAs to 2009/2010, that were not delivered in 2008/2009?
|
21/05/2009
|
|
01/06/2009
|
|
61
|
The number of minor surgical procedures performed by GPs in your PCT as part of a locally enhanced service each year for the last five years, and the level or reimbursement paid
The number of minor surgical procedures performed by GPs in your PCT as part of a direct enhanced service each year for the last five years; and the level or reimbursement paid
The number of minor surgical procedures performed by GPs as part of a national enhanced service in your PCT each year for the last five years; and the level or reimbursement paidThe number of minor surgical procedures performed by GPs as part of an additional service in your PCT each year for the last five years; and the level or reimbursement paid
The number of minor surgical procedures performed by GPs as part of a specialist provider medical service (SPMS) in your PCT each year for the last five years; and the level or reimbursement paid
The number of GPs in your PCT that have met the PCT's accreditation criteria as a GP with a specialist interest in dermatology and/or skin surgery as of May 2009
The number of GPs in your PCT that have failed to meet the PCT's accreditation criteria as a GP with a specialist interest in dermatology and/or skin surgery.
|
26/05/2009
|
|
22/06/209
|
|
62
|
I would like to request a breakdown of the job title of every paid post within the trust as well as the average salary for each post.
|
27/05/2009
|
|
03/06/2009
|
|
63
|
1. How many specialist bereavement midwife counsellor (BMC) there are currently at each acute hospital with maternity services within your Primary Care Trust Region. 2) Have you made this position redundant within the last 5 years; if yes are there any plans to re-instigate this position? 3. How many BMCs were employed in the trust in 2005? 4. How many BMCs were employed in the trust in 2006? 5. How many BMCs were employed in the trust in 2007? 6. How many BMCs were employed in the trust in 2008? 7. If no BMC is employed what is the job title of the individual responsible for bereavement counselling?
|
02/06/2009
|
|
02/06/2009
|
|
64-75
|
Please confirm or deny if your Primary Care Trust uses protocols to determine whether to reimburse a funding request for a medicine to be used outside its licensed indications (i.e. ‘off-label use’)
Please supply the protocols used by your Primary Care Trust to determine whether to reimburse a funding request for a medicine to be used outside its licensed indications (i.e. ‘off-label use’)
Please supply a list of the medicines for cancer which your Primary Care Trust currently funds routinely outside of their licensed indications
Please supply a list of the five most-commonly requested medicines for cancer for use outside their licensed indications in each of the least three years
Please supply the total number of requests for the funding of a cancer medicine to be used outside of its licensed indication in each of the last three years which were approved, broken down by cancer medicine if possible
Please supply the total number of requests for the funding of a cancer medicine to be used outside of its licensed indication in each of the last three years which were rejected, broken down by cancer medicine if possible
Please supply the form used by clinicians to apply for funding for their patients for medicines to be used outside their licensed indication.
Please confirm or deny that your Primary Care Trust has reimbursed any patients for the costs they incurred privately in purchasing cancer treatments which were initially not funded on the NHS but subsequently funded following appeal.
Please supply the total number of patients in each of the last three years which your Primary Care Trust has reimbursed for the costs they incurred privately in purchasing cancer treatments which were initially not funded on the NHS but subsequently funded following appeal.
Please supply the total sum of money in each of the last three years which your Primary Care Trust reimbursed to patients for the costs they incurred privately in purchasing cancer treatments which were initially not funded on the NHS but subsequently funded following appeal.
Please confirm or deny if your Primary Care Trust holds information on the number of patients requiring treatment for cancer who initially paid for a part of their treatment privately but subsequently received all of their treatment paid for by your Primary Care Trust over the last three years.
Please supply the information your Primary Care Trust holds on the number of patients requiring treatment for cancer who initially paid for a part of their treatment privately but subsequently received all of their treatment paid for by your Primary Care Trust over the last three years.
|
28/05/2009
|
|
29/06/2009
|
|
76
|
1. The amount spent on consultancy services (individual and/or companies) for the financial years 2006-2007, 2007-2008 and 2008-2009. 2. The names of and the projects/work undertaken by consultancy service providers (individuals and/or companies) for the financial years 2006-2007, 2007-2008 and 2008-2009. I understand the legal requirement is to return the information requested within 20 days; however your help in returning all or some of it as quickly as possible is greatly appreciated.
|
28/05/2009
|
|
02/06/2009
|
|
77
|
Would you confirm how much your Non-Executive Directors receive in gross income, that Jeremy Birch is currently a Non-Executive Director, and that he receives this payment from you.
|
01/06/2009
|
|
18/06/2009
|
|
78
|
Please provide the following details:
At your organisation is there a board member or senior manager entrusted with specific responsibility for investigating staff concerns raised on confidence?
a: Please state this person’s name and job title.
b: How many such concerns have been raised in the past 10 years OR for the most recent time period for which figures are available?
What percentage of staff at your organisation have confidentiality clauses in their employment contracts OR severance agreements?
How many complaints OR employment tribunals have there been relating to your organisation in the past 10 years OR during the most recent time period for which figures are available, concerning staff claiming victimisation as a result of disclosing information?
a: Please provide details of the verdict and penalties associated with any tribunals concerning staff at your organisation claiming victimisation as a result of disclosing information.
4. Please provide a copy of your organisation’s whistleblowing policy.
|
01/06/2009
|
|
23/06/2009
|
|
79
|
1. Does the PCT have a respiratory disease lead?
2. Has the PCT made any assessment of variations across the PCT in
proportions of people whose asthma is well controlled? If so, what were
the findings of this assessment?
3. Has the PCT used disease information management tools to analyse the
number of emergency bed days attributable to asthma attacks?
4. Has the PCT performed any analysis of differences in prescribing of
respiratory medicines across health care providers in the PCT? If so,
did this analysis examine links between prescribing practice and markers
of poor asthma control?
5. Does the PCT impose any restrictions (or have any guidelines) on the
prescription for the treatment of asthma of combination drugs, branded
drugs or treatments?
|
01/06/2009
|
|
23/06/2009
|
|
81
|
please could you send me the PBC plans for each PBC cluster in Hastings and Rother and East Sussex Downs and Weald. for 09/10. Please could you also send me a list of PBC structure, with contact details (ie who the chair is , which GP leads on each area etc)
|
02/06/2009
|
|
18/06/2009
|
|
82
|
1. Are the out-of-hours (OOH) care in your PCT contracted out to a third party? If yes, please answer the following questions:2. The numbers for all OOH contracts awarded or currently out to tender as of 3 June 2009. 3. The bidders for and terms of all OOH contracts awarded, including the services contracted by volume and value, number of patients, and duration of contract: a) details of the successful bidder (or preferred bidder if process not fully completed yet) including bidder name, state of incorporation (private or public limited company, Social Enterprise or CIC, UK registered branch of overseas company, other legal status – please specify); as well as the names and company status of any unsuccessful bidders; b) patient numbers; c) value of the new contract; d) duration of the new contract. 4. Who provides the staffing for OOH care (Locums, salaried doctors, overseas doctors)? 5. For all completed tenders, the criteria and the methodology underpinning each contract award (e.g. scoring system). 6. The arrangements in place for contract monitoring and enforcement.
|
02/06/2009
|
|
30/06/2009
|
|
83
|
1.Please state how much your trust spent on nursing, midwifery and health visiting staff (staff coded N in the National Health Service Occupational Code Manual) 2. Please state how much your trust spent on medical and dental staff (staff coded M in the National Health Service Occupational Code Manual) 3. Please state how much your trust spent on managers and senior managers (staff coded G0 and G1 in the National Health Service Occupational Code Manual) In each case please include spending on pay and non-pay costs as well as spending on any agency staff within each category. By ‘non-pay’ I mean costs in respect of National Insurance etc, which aren’t included in the pay the staff member receives but which are still a cost to the Trust. 4. For each of the categories in questions 1 to 3, please state how many staff members are currently paid more than £100,000 per annum.
|
02/06/2009
|
|
15/06/2009
|
|
85
|
Please can you send me either:Your primary care prescribing formulary if it has changed/been updated since March 2009? Or a list of the updates/changes to your primary care prescribing formulary since March 2009
|
03/06/2009
|
|
15/06/2009
|
|
89
|
How much of the additional £330m has your PCT a) received and b) invested in maternity services for the year 2008/09? How much of the additional £330m has/will your PCT be a) receiving and b) investing in maternity services for the year 2009/10?
|
05/06/2009
|
|
30/06/2009
|
|
92
|
1) How much has your trust paid out in each of the past four years (2005, 2006, 2007 and 2008) for IVF treatment. 2) How many such requests for IVF has the trust received and how many were granted? 3) How many such requests were refused? 4) If they were refused what were the grounds given? 1) How many requests for exceptional funding for treatments were issued, where there is no Nice guidance. Please provide details of the requests received and granted in each year for the last four years. 2) Please explain how your PCT handles exceptional case funding requests. 3) How many requests for funding under the ‘exceptional case’ definition were received in each of the last four years? 4) How many were granted in each of the last four years? And what was the total cost per year? 5) If the request was refused, what were the grounds? 6) What proportion of requests were for a) cancer drugs b) fertility treatment c) other. Please give names of drugs or treatments listed in ‘c – other’
|
12/06/2009
|
|
30/06/2009
|
|
96
|
I would like detailed expenditure of PCT Public Monies spent specifically on the building which includes the surgery and offices at 39-43 Sea Road, Bexhill-on-Sea during the last five years, as of today’s date.
|
15/06/2009
|
|
23/06/2009
|
|
103
|
Please could you answer the following questions relevant to Mental Health services in the PCT area. 1) The Amount spent on Adult Mental Health services (provided and commissioned) in 2007/2008 & 2008/2009 and forecast for 2009&2010 2) What types of Adult Mental Health services this money was spent on, and the amount received. For example - Adult Mental Health secure services £x
|
19/06/2009
|
|
25/06/2009
|
|
105
|
Would it be possible to have a copy of the endocrinology HEMC formulary
|
24/06/2009
|
|
25/06/2009
|
|
106-112
|
a) Details on Trust’s policy on the prescription of the drug Bortezomib for the treatment of Multiple Myeloma (bone marrow cancer) and a copy of any guidance issued to clinicians on the prescription of Bortezomib. b) How many patients were prescribed with the drug Bortezomib (commonly known as Velcade) in (a) 2004/5; (b) 2005/6; (c) 2006/7; (d) 2007/8; and (e) 2008/9
a) Details on Trust’s policy on the prescription of the drug Cetuximab for the treatment of cancer (head and neck; and large bowel) and a copy of any guidance issued to clinicians on the prescription of Cetuximab. b) How many patients were prescribed with the drug Cetuximab (commonly known as Erbitux) in (a) 2004/5; (b) 2005/6; (c) 2006/7; (d) 2007/8; and (e) 2008/9
a)Details on Trust’s policy on the prescription of the drug Rituximab for the treatment of Non Hodgekin’s Lymphoma and a copy of any guidance issued to clinicians on the prescription of Rituximab. b) How many patients were prescribed with the drug Rituximab (commonly known as Rituxan or Mabthera) in (a) 2004/5; (b) 2005/6; (c) 2006/7; (d) 2007/8; and (e) 2008/9
a)Details on Trust’s policy on the prescription of the drug (i) Donepezil, (ii) Rivastigmine and (iii) Galantamine for the treatment of Alzheimer’s Disease and a copy of any guidance issued to clinicians on the prescription of (i) Donepezil, (ii) Rivastigmine and (iii) Galantamine b) How many patients were prescribed with the drug (i) Donepezil, (ii) Rivastigmine and (iii) Galantamine (commonly known as (i) Aricept, (ii) Rituxan or (iii) Mabthera) in (a) 2004/5; (b) 2005/6; (c) 2006/7; (d) 2007/8; and (e) 2008/9
a) Details on Trust’s policy on the prescription of the drug Rituximab for the treatment of Breast Cancer and a copy of any guidance issued to clinicians on the prescription of Trastuzemun. b) How many patients were prescribed with the drug Trastuzemun (commonly known as Herceptin) in (a) 2004/5; (b) 2005/6; (c) 2006/7; (d) 2007/8; and (e) 2008/9
a) Details on Trust’s policy on the prescription of the drug Imatinib for the treatment of Chronic Myeloid (Leukemia) and a copy of any guidance issued to clinicians on the prescription of Imatinib. b) How many patients were prescribed with the drug Imatinib (commonly known as Gleevec) in (a) 2004/5; (b) 2005/6; (c) 2006/7; (d) 2007/8; and (e) 2008/9
|
26/07/2009 |
|
30/06/2009 |
